Diagnostic and prognostic value of H-ficolin for functionally relevant coronary artery disease

Ganna Isayeva1, Eliska Potlukova2, Klara Rumora1

  • 1Cardiovascular Research Institute Basel (CRIB), University Heart Center, University Hospital Basel, University of Basel, Switzerland.

Insights

H-ficolin, a complement system protein, showed no diagnostic or prognostic value for functionally relevant coronary artery disease (fCAD). This study found no significant association between H-ficolin levels and fCAD diagnosis or cardiovascular outcomes.

Area of Science:

  • Cardiovascular Medicine
  • Immunology
  • Complement System

Background:

  • H-ficolin initiates the lectin pathway of the complement system.
  • Investigating H-ficolin's role in coronary artery disease (CAD) is crucial for understanding cardiovascular health.
  • The diagnostic and prognostic capabilities of H-ficolin in functionally relevant CAD (fCAD) require further elucidation.

Purpose of the Study:

  • To evaluate the diagnostic and prognostic utility of H-ficolin in patients with suspected fCAD.
  • To explore potential determinants of H-ficolin levels in this patient cohort.

Main Methods:

  • Utilized myocardial perfusion imaging and coronary angiography to diagnose fCAD in 1,571 patients.
  • Measured H-ficolin levels using immunoassay at rest, peak stress, and 2 hours post-stress.
  • Assessed cardiovascular death and non-fatal myocardial infarction over a 5-year follow-up period.

Main Results:

  • H-ficolin levels did not differ significantly between patients with and without fCAD (AUC 0.53).
  • H-ficolin was not a predictor of cardiovascular events in the overall cohort.
  • A potential association was observed between H-ficolin and non-fatal myocardial infarction in patients without fCAD.

Conclusions:

  • H-ficolin concentration lacks diagnostic and prognostic value for patients undergoing evaluation for fCAD.
  • No significant correlation was found between H-ficolin and the presence of fCAD.
  • Further research may be needed to clarify the specific role of H-ficolin in certain subgroups, such as patients without fCAD.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
9
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
22
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
12
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
11
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
19
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
101